The company is asking for customers to identify and destroy 51 human and 33 animal drug products, according to an April 26 post from the FDA. Some of the recalled human drugs include albuterol, lorazepam and naloxone.
“The discontinuation of the quality program means the company will not be able to support or guarantee that the products will meet all intended specifications through the labeled shelf life of the product,” the FDA said. “Further distribution or use of any remaining product on the market should cease immediately.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
